Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries NIDA Avails $1.5M for Research on Drug Addiction Treatment Using Psychedelics By: Investor Brand Network May 24, 2023 at 15:34 PM EDT Decades after lawmakers launched the purported “war on drugs” to curb drug addiction and criminal activity that supported the drug trade, drugs still have a large portion of the American population under their grip. Data from the Association of American Medical Colleges shows that by December 2019, 21 million Americans were suffering from some kind of drug addiction. The stigma around drug addiction and mental health coupled with limited access to adequate treatment facilities means that a majority of Americans with… Read More>> NOTE TO INVESTORS: The latest news and updates relating to Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) are available in the company’s newsroom at https://ibn.fm/DELCF About PsychedelicNewsWire PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics. To receive instant SMS alerts, text “Groovy” to 844-397-5787 (U.S. Mobile Phones Only) For more information please visit https://www.psychedelicnewswire.com Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer Do you have questions or are you interested in working with PNW? Ask our Editor PsychedelicNewsWire (PNW)San Francisco, Californiawww.psychedelicnewswire.com415.949.5050 OfficeEditor@PsychedelicWire.com PsychedelicNewsWire is part of the InvestorBrandNetwork. Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
NIDA Avails $1.5M for Research on Drug Addiction Treatment Using Psychedelics By: Investor Brand Network May 24, 2023 at 15:34 PM EDT Decades after lawmakers launched the purported “war on drugs” to curb drug addiction and criminal activity that supported the drug trade, drugs still have a large portion of the American population under their grip. Data from the Association of American Medical Colleges shows that by December 2019, 21 million Americans were suffering from some kind of drug addiction. The stigma around drug addiction and mental health coupled with limited access to adequate treatment facilities means that a majority of Americans with… Read More>> NOTE TO INVESTORS: The latest news and updates relating to Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) are available in the company’s newsroom at https://ibn.fm/DELCF About PsychedelicNewsWire PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics. To receive instant SMS alerts, text “Groovy” to 844-397-5787 (U.S. Mobile Phones Only) For more information please visit https://www.psychedelicnewswire.com Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer Do you have questions or are you interested in working with PNW? Ask our Editor PsychedelicNewsWire (PNW)San Francisco, Californiawww.psychedelicnewswire.com415.949.5050 OfficeEditor@PsychedelicWire.com PsychedelicNewsWire is part of the InvestorBrandNetwork.
Decades after lawmakers launched the purported “war on drugs” to curb drug addiction and criminal activity that supported the drug trade, drugs still have a large portion of the American population under their grip. Data from the Association of American Medical Colleges shows that by December 2019, 21 million Americans were suffering from some kind of drug addiction. The stigma around drug addiction and mental health coupled with limited access to adequate treatment facilities means that a majority of Americans with… Read More>> NOTE TO INVESTORS: The latest news and updates relating to Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) are available in the company’s newsroom at https://ibn.fm/DELCF About PsychedelicNewsWire PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics. To receive instant SMS alerts, text “Groovy” to 844-397-5787 (U.S. Mobile Phones Only) For more information please visit https://www.psychedelicnewswire.com Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer Do you have questions or are you interested in working with PNW? Ask our Editor PsychedelicNewsWire (PNW)San Francisco, Californiawww.psychedelicnewswire.com415.949.5050 OfficeEditor@PsychedelicWire.com PsychedelicNewsWire is part of the InvestorBrandNetwork.